EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation

por Diefenbach, Konstanze, Trummer, Dietmar, Ebert, Frank, Lissy, Michael, Koch, Manuela, Rohde, Beate, Blode, Hartmut
Publicado 2013

Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects

por Gerisch, Michael, Hafner, Frank-Thorsten, Lang, Dieter, Radtke, Martin, Diefenbach, Konstanze, Cleton, Adriaan, Lettieri, John
Publicado 2017

Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models

por Zopf, Dieter, Fichtner, Iduna, Bhargava, Ajay, Steinke, Wolfram, Thierauch, Karl‐Heinz, Diefenbach, Konstanze, Wilhelm, Scott, Hafner, Frank‐Thorsten, Gerisch, Michael
Publicado 2016